34J-15852-62505
3 vaccinations
11 coded responses
32 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 480 / MI
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Moderna
-
2021-02-24
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Flushing — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Flushing, asthmatic coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Moderna
-
2021-03-24
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Tinnitus — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Tinnitus — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Tinnitus — Feeling: Good · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — day 7, dose 2MedDRA: Tinnitus — Feeling: Good · Fatigue or tirednessFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-14
-
2021-04-21
Survey response — day 28, dose 2MedDRA: Tinnitus — Feeling: Good · Be unable to do your normal daily activitiesFree text: My tinnitus continues and there a a question of hearing loss. Im having a hearing test done to evaluate.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — day 35, dose 2MedDRA: Ear disorder, Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Nausea associated with ear problem that remains unresolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Survey response — day 42, dose 2MedDRA: Deafness, Inflammation, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: On prednisone from inflammation, hearing loss and abnormal acoustic nerve reflexes. Requires insulin.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-23
- 2021-09-23
-
2021-12-20
Dose 3 — Pfizer-BioNTech
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-27
Health check-in — day 7, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-03
Survey response — day 14, dose 3MedDRA: Hypoaesthesia, Nausea, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea and numbness/tingling of the head with movement.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Survey response — day 21, dose 3MedDRA: Hypoaesthesia, Nausea, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cannot hold head down without major nausea and numbness/tingling of the head.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-22
-
2022-12-22
Survey response — 12 months, dose 3MedDRA: Asthenia, Gait disturbance, Hypoaesthesia, Muscle spasticity, Paraesthesia, Physiotherapy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have continued issues from episode following Moderna, spasticity, continued PT to correct weakness, numbness/tingling and gait disturbances. Compromised immune system from steroid treatments following the shot.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Moderna | |
| 2 | 2021-03-24 | Moderna | |
| 3 | 2021-12-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Flushing, asthmatic cough
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Tinnitus
Systemic reaction (other): Tinnitus
Systemic reaction (other): Tinnitus
Release 6 — day 7, dose 2
Systemic reaction (other): Tinnitus
Release 7 — day 28, dose 2
Symptoms: My tinnitus continues and there a a question of hearing loss. Im having a hearing test done to evaluate.
Release 8 — day 35, dose 2
Symptoms: Nausea associated with ear problem that remains unresolved.
Release 8 — day 42, dose 2
Symptoms: On prednisone from inflammation, hearing loss and abnormal acoustic nerve reflexes. Requires insulin.
Release 10 — day 14, dose 3
Symptoms: Nausea and numbness/tingling of the head with movement.
Release 10 — day 21, dose 3
Symptoms: Cannot hold head down without major nausea and numbness/tingling of the head.
Release 12 — 12 months, dose 3
Symptoms: I have continued issues from episode following Moderna, spasticity, continued PT to correct weakness, numbness/tingling and gait disturbances. Compromised immune system from steroid treatments following the shot.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Deafness | ✓ | ✓ | ✓ |
| SD | Ear disorder | ✓ | ✓ | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Muscle spasticity | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Physiotherapy | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Tinnitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release